16875-31-3 Usage
Type
Carbonic anhydrase inhibitor
Uses
Treatment of glaucoma, epilepsy, and altitude sickness
Mechanism (glaucoma)
Reduces production of aqueous humor in the eye, lowering intraocular pressure and relieving symptoms of glaucoma
Mechanism (epilepsy)
Inhibits the enzyme carbonic anhydrase, reducing abnormal electrical discharges in the brain that lead to seizures
Mechanism (altitude sickness)
Decreases symptoms of dizziness, headache, nausea, and shortness of breath experienced at high altitudes
Other use
As a diuretic to increase urine production and treat fluid retention
Importance
Has a wide range of medical applications and is an important medication in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 16875-31-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,8,7 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16875-31:
(7*1)+(6*6)+(5*8)+(4*7)+(3*5)+(2*3)+(1*1)=133
133 % 10 = 3
So 16875-31-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O4/c6-3(8)1-2-4(9)11-5(10)7-2/h2H,1H2,(H2,6,8)(H,7,10)
16875-31-3Relevant academic research and scientific papers
ENANTIOMERIC QUANTIFICATIONS OF AMINO ACIDS THROUGH THEIR Nα-ACYL AMIDES BY GAS CHROMATOGRAPHY.
Hosten, N.,Anteunis, M. J. O.
, p. 45 - 47 (2007/10/02)
Apparent separation of 1.1 or higher on Chiralsil Val III can be obtained for Nα-acyl N-alkyl aminoacid amides allowing the use of short capillary gas chromatographic columns.A clean derivatization protocol without racemization is described, proceding through the NCA derivatives that are prepared from "in situ" silylated amino acids with trimethylsilyl cyanide.
